Treatment of narcolepsy with codeine - PubMed (original) (raw)

Clinical Trial

Treatment of narcolepsy with codeine

J M Fry et al. Sleep. 1986.

Abstract

The effectiveness of codeine as a treatment for the excessive daytime sleepiness of narcolepsy was studied in two experimental trials. In an open trial of codeine in five narcoleptic subjects, dramatic clinical improvement was reported. However, all-night polysomnography and maintenance of wakefulness tests before and after codeine showed no significant differences. A double-blind placebo-codeine trial was conducted in which eight narcoleptic subjects received codeine for 1 week and placebo for 1 week in a random order. During the week they kept a diary, and on the sixth evening and for 10 h following awakening on the seventh day they were monitored by radiotelemetry in the sleep laboratory for electroencephalogram, electro-oculogram, and electromyogram. The results were analyzed for sleep stages as well as four levels of wakefulness. The results showed no significant differences in any of the objective sleep or wakefulness parameters. However, the diaries showed significantly fewer naps during the week on codeine as compared with the placebo week. Eighteen of 27 narcoleptic patients treated with codeine report clinical improvement. Codeine consistently results in subjective clinical improvement. However, this is not reflected in the objective measures generally used to assess daytime sleepiness.

PubMed Disclaimer

Similar articles

• Ritanserin improves sleep quality in narcolepsy.
  Mayer G. Mayer G. Pharmacopsychiatry. 2003 Jul;36(4):150-5. doi: 10.1055/s-2003-41200. Pharmacopsychiatry. 2003. PMID: 12905101 Clinical Trial.
• A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
  Xyrem International Study Group. Xyrem International Study Group. J Clin Sleep Med. 2005 Oct 15;1(4):391-7. J Clin Sleep Med. 2005. PMID: 17564408 Clinical Trial.
• Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study.
  Mayer G, Ewert Meier K, Hephata K. Mayer G, et al. Clin Neuropharmacol. 1995 Aug;18(4):306-19. doi: 10.1097/00002826-199508000-00002. Clin Neuropharmacol. 1995. PMID: 8665543 Clinical Trial.
• Narcolepsy in the older adult: epidemiology, diagnosis and management.
  Chakravorty SS, Rye DB. Chakravorty SS, et al. Drugs Aging. 2003;20(5):361-76. doi: 10.2165/00002512-200320050-00005. Drugs Aging. 2003. PMID: 12696996 Review.
• Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
  Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y. Boscolo-Berto R, et al. Sleep Med Rev. 2012 Oct;16(5):431-43. doi: 10.1016/j.smrv.2011.09.001. Epub 2011 Nov 4. Sleep Med Rev. 2012. PMID: 22055895 Review.

Cited by

• A normative study of the maintenance of wakefulness test (MWT).
  Doghramji K, Mitler MM, Sangal RB, Shapiro C, Taylor S, Walsleben J, Belisle C, Erman MK, Hayduk R, Hosn R, O'Malley EB, Sangal JM, Schutte SL, Youakim JM. Doghramji K, et al. Electroencephalogr Clin Neurophysiol. 1997 Nov;103(5):554-62. doi: 10.1016/s0013-4694(97)00010-2. Electroencephalogr Clin Neurophysiol. 1997. PMID: 9402886 Free PMC article. Review.
• Narcolepsy.
  Mitler MM, Hajdukovic R, Erman M, Koziol JA. Mitler MM, et al. J Clin Neurophysiol. 1990 Jan;7(1):93-118. doi: 10.1097/00004691-199001000-00008. J Clin Neurophysiol. 1990. PMID: 1968069 Free PMC article.
• Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
  Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E, Scammell TE. Crocker A, et al. Neurology. 2005 Oct 25;65(8):1184-8. doi: 10.1212/01.wnl.0000168173.71940.ab. Epub 2005 Sep 14. Neurology. 2005. PMID: 16247044 Free PMC article.
• Relative efficacy of drugs for the treatment of sleepiness in narcolepsy.
  Mitler MM, Hajdukovic R. Mitler MM, et al. Sleep. 1991 Jun;14(3):218-20. doi: 10.1093/sleep/14.3.218. Sleep. 1991. PMID: 1680245 Free PMC article. Clinical Trial.
• Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy.
  Thannickal TC, John J, Shan L, Swaab DF, Wu MF, Ramanathan L, McGregor R, Chew KT, Cornford M, Yamanaka A, Inutsuka A, Fronczek R, Lammers GJ, Worley PF, Siegel JM. Thannickal TC, et al. Sci Transl Med. 2018 Jun 27;10(447):eaao4953. doi: 10.1126/scitranslmed.aao4953. Sci Transl Med. 2018. PMID: 29950444 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems